WAINUA® is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR).
Approximately 2,000 people in the U.S. are living with hATTR. It help raise awareness of this rare disease that impacts neurological function and impacts organs if left untreated, and to promote WAINUA as possible treatment, we created a launch campaign for the brand. I led the copy development and content strategy for the consumer launch which included a website design, consumer brochure, doctor discussion guide, and an email campaign that helps people taking the medicine to stay the course and further educates them about the disease.
Agency: Hill Holliday Health
Role: Group Copy Supervisor
UX Designer: Emily Capece
Creative Directors: James Amadeo/Matt Flandorfer
Link: www.WAINUA.com